DK2906237T3 - Multivalent heteromultimer scaffold design og konstrukter - Google Patents

Multivalent heteromultimer scaffold design og konstrukter Download PDF

Info

Publication number
DK2906237T3
DK2906237T3 DK13816831.5T DK13816831T DK2906237T3 DK 2906237 T3 DK2906237 T3 DK 2906237T3 DK 13816831 T DK13816831 T DK 13816831T DK 2906237 T3 DK2906237 T3 DK 2906237T3
Authority
DK
Denmark
Prior art keywords
constructes
scaffold design
multivalent
multivalent heteromultimer
heteromultimer scaffold
Prior art date
Application number
DK13816831.5T
Other languages
English (en)
Inventor
Surjit Bhimarao Dixit
Igor Edmondo Paolo D'angelo
Mario Sanches
Gordon Yiu Kon Ng
Original Assignee
Zymeworks Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymeworks Inc filed Critical Zymeworks Inc
Priority claimed from PCT/US2013/050408 external-priority patent/WO2014012082A2/en
Application granted granted Critical
Publication of DK2906237T3 publication Critical patent/DK2906237T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2809—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against the T-cell receptor (TcR)-CD3 complex
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/31—Fusion polypeptide fusions, other than Fc, for prolonged plasma life, e.g. albumin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
DK13816831.5T 2012-07-13 2013-07-12 Multivalent heteromultimer scaffold design og konstrukter DK2906237T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201261671640P 2012-07-13 2012-07-13
US201261697245P 2012-09-05 2012-09-05
US201361758701P 2013-01-30 2013-01-30
PCT/US2013/050408 WO2014012082A2 (en) 2012-07-13 2013-07-12 Multivalent heteromultimer scaffold design an constructs

Publications (1)

Publication Number Publication Date
DK2906237T3 true DK2906237T3 (da) 2020-07-13

Family

ID=53539323

Family Applications (1)

Application Number Title Priority Date Filing Date
DK13816831.5T DK2906237T3 (da) 2012-07-13 2013-07-12 Multivalent heteromultimer scaffold design og konstrukter

Country Status (4)

Country Link
EP (1) EP2906237B8 (da)
DK (1) DK2906237T3 (da)
ES (1) ES2805361T3 (da)
HK (1) HK1212615A1 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3749331A4 (en) * 2018-02-06 2021-08-04 Mayo Foundation for Medical Education and Research ANTIBODY PEPTIDE COMPLEX AND THEIR USES

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5841046B2 (ja) * 2009-04-08 2016-01-06 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 制御された血清中薬物動態を有するヒトタンパク質スキャフォールド
WO2012116453A1 (en) * 2011-03-03 2012-09-07 Zymeworks Inc. Multivalent heteromultimer scaffold design and constructs

Also Published As

Publication number Publication date
EP2906237B1 (en) 2020-04-15
HK1212615A1 (zh) 2016-09-15
EP2906237A4 (en) 2016-10-05
EP2906237B8 (en) 2020-08-19
ES2805361T3 (es) 2021-02-11
EP2906237A2 (en) 2015-08-19

Similar Documents

Publication Publication Date Title
DK2928496T3 (da) Crispr-baseret genommodifikation og -regulering
DK2920313T3 (da) Rekombinante adenovira og anvendelse deraf
DK2850202T3 (da) Fremgangsmåder og grupper
DK2855736T3 (da) Elektrolysator og energisystem
DK3608325T3 (da) Polycykliske-carbamoylpyridonforbindelser og deres farmaceutiske anvendelse
DK2903600T3 (da) Virusholdig formulering og anvendelse deraf
DK3043784T3 (da) Arylethere og anvendelser deraf
DK3196022T3 (da) Trykningssystem og fremgangsmåde
EP2681245A4 (en) DESIGN AND CONSTRUCTIONS FOR A MULTIVALENT HETEROMULTIMERES SCAFFOLD
DK3415157T3 (da) N-acyldipeptidderivater og anvendelser deraf
DK3003039T3 (da) Methyl/fluor-pyridinyl-metoxy-substituerede pyridinon-pyridinyl-forbindelser og fluor-pyrimidinyl-metoxy-substituerede pyridinon-pyridinyl-forbindelser
DK2962100T3 (da) Tuberkulosebiomarkører og anvendelser deraf
DK2917181T3 (da) Heteroarylderivater og anvendelser deraf
DK3326642T3 (da) Langtidsvirkende koagulationsfaktorer og brugen deraf
DK3029038T3 (da) Tetrazolinonforbindelse og anvendelse deraf
DK2880228T3 (da) Stilladsstruktur
DK2903896T3 (da) Baneindretning
DK2809669T3 (da) Kondenserede pyrroldicarboxamider og deres anvendelse som farmaceutika
DK3392252T3 (da) Pyrimido-pyridazinonforbindelser og deres anvendelse
BR112015007217A2 (pt) compostos e usos do composto
DK2877736T3 (da) Skrue, skruedel og fremgangsmåde dertil
DK2849798T3 (da) Oligonukleotid-chelatkompleks-polypeptidsammensætninger og fremgangsmåder
DK2943460T3 (da) 6-chlor-3-(phenyl-d5)-inden-1-on og anvendelse deraf
DK2805954T3 (da) 7-substitueret hanfangichin b-derivat, og fremstillingsfremgangsmåde og anvendelse deraf
BR302012003711S1 (pt) Configuração aplicada em abrigo